相关实验视频
Updated: May 11, 2026

Purification of Transcripts and Metabolites from Drosophila Heads
Published on: March 15, 2013
轴作为一个潜在的治疗瘤的潜在治疗标:基于单核RNA-seq和空间转录组概况
Yiguang Chen1, Xiaohai Liu2, Yilamujiang Ainiwan3
1Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, China; China International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University, Beijing, 100053, China; Department of Neurosurgery, Nanfang Hospital, Southern Medical University, No. 1838, Guangzhou North Road, Guangzhou, Guangdong, 510515, China.
亚当丁瘤性膜瘤 (ACP) 涉及与癌症相关的纤维细胞分泌促进瘤生长的蛋白质. 向AXL受体显示出抑制ACP进展和增强免疫治疗的希望.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 瘤微环境 瘤微环境
背景情况:
- 亚当丁诺马图斯膜瘤 (ACP) 经常复发,并导致严重的内分泌/下丘脑功能障碍.
- 瘤微环境在ACP进展中的作用仍然不完全理解.
研究的目的:
- 在ACP瘤微环境中探索新的向疗法.
- 为了研究与癌症相关的纤维细胞 (CAFs) 在非洲和非洲的功能.
主要方法:
- 在ACP瘤组织中识别和描述CAF.
- 分析CAF和瘤细胞的蛋白质分泌 (PROS1,GAS6).
- 评估AXL受体激活及其对瘤细胞的下游影响.
- 在体外评估AXL抑制剂 (Bemcentinib) 和免疫疗法 (Atezolizumab) 的疗效.
主要成果:
- 在ACP中确定了CAF,与特征性瘤特征共定位.
- CAF和瘤细胞分泌PROS1和GAS6,激活瘤上皮质上的AXL受体.
- 在ACP中,AXL激活促进免疫抑制和瘤进展.
- 贝姆森丁尼布抑制了ACP有机物增殖,并增强了阿特佐利祖马布的疗效.
结论:
- AXL信号通路与ACP的进展和免疫逃避有关.
- AXL代表了Adamantinomatous Craniopharyngiomas的一个潜在的治疗点.
- 针对AXL和免疫检查点的组合疗法可以改善治疗结果.
更多相关视频
11:24Detection of Axonally Localized mRNAs in Brain Sections Using High-Resolution In Situ Hybridization
Published on: June 17, 2015
05:40AAV Systems and Mouse Models for Investigating Ectopic Expression of Neurod1 in Transduced Cells at Subacute and Chronic Times Post-Ischemic Stroke
Published on: November 29, 2024
相关概念视频
lncRNA - Long Non-coding RNAs
Targeted Cancer Therapies
There are several types of targeted therapies against specific...